id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-318873-zwot69s3	Braunstein, Eric D.	Inpatient Cardiac Monitoring Using a Patch‐Based Mobile Cardiac Telemetry System During the COVID‐19 Pandemic	2020-08-27		.txt	text/plain	4519	232	41	In order to be eligible for device placement, patients on non-ICU and non-telemetry capable hospital units and were suggested to meet at least one of the following criteria: Prolonged QT on admission ECG defined as QTc > 470 ms for males or > 480 ms for females and considered for treatment with agents which can further prolong the QT interval, history of QT prolongation in the past with pharmacologic therapy, anticipated therapy with two or more agents capable of QT prolongation (e.g. hydroxychloroquine + azithromycin or methadone), high oxygen supplementation requirements (e.g. non-rebreather mask, high-flow nasal cannula, or ventilator support), or history of or concern for arrhythmias. Additional study outcomes were incidence of significant prolongation of the QT interval, defined as QTc (calculated using the Bazett formula) ≥ 500 ms or increase in the QTc ≥ 60 ms from baseline ECG, 13 incidence of atrial fibrillation during hospitalization (which included atrial fibrillation that occurred outside of the monitoring period), myocarditis/myocardial injury or heart failure during admission, and death.	./cache/cord-318873-zwot69s3.txt	./txt/cord-318873-zwot69s3.txt